MOCHIDA PHARMACEUTICAL CO., LTD. Toevoegen aan een lijst
|
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 3.190 JPY | -0,47% |
|
+1,43% | -2,45% |
| 25/04 | Hidehiro Imatsu benoemd tot president van Goldman Sachs Japan | RE |
| 05/02 | Mochida Pharmaceutical Co, Ltd. Geeft dividendvoorspelling voor het jaar dat eindigt op 31 maart 2024 | CI |
Totale waarde
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 225.342 | 161.603 | 164.177 | 141.444 | 116.879 | 113.178 | - | - |
| Bedrijfswaarde 1 | 166.311 | 100.313 | 100.691 | 79.530 | 56.370 | 50.211 | 49.036 | 46.601 |
| K/w-verhouding | 26,7 x | 35,5 x | 19,3 x | 13,5 x | 18,7 x | 25,7 x | 19,2 x | 17 x |
| Dividendrendement | 1,5% | 1,92% | 2,1% | 2,41% | 2,4% | 2,51% | 2,51% | 2,51% |
| Marktkapitalisatie/omzet | 2,06 x | 1,59 x | 1,59 x | 1,28 x | 1,13 x | 1,11 x | 1,07 x | 1,05 x |
| Bedrijfswaarde/omzet | 1,52 x | 0,99 x | 0,98 x | 0,72 x | 0,55 x | 0,49 x | 0,46 x | 0,43 x |
| Bedrijfswaarde/EBITDA | 12,3 x | 8,69 x | 6,83 x | 4,66 x | 5,04 x | 6,05 x | 4,86 x | 4,24 x |
| Bedrijfswaarde/FCF | 14.762.172 x | - | - | - | 10.986.079 x | - | 13.376.003 x | 9.477.614 x |
| FCF Yield | 0% | - | - | - | 0% | - | 0% | 0% |
| Price to Book | 1,78 x | 1,34 x | 1,29 x | 1,09 x | 0,96 x | 0,88 x | 0,86 x | 0,84 x |
| Aantal aandelen (in duizenden) | 39.673 | 38.754 | 38.270 | 37.870 | 34.994 | 35.479 | - | - |
| Referentieprijs 2 | 5.680 | 4.170 | 4.290 | 3.735 | 3.340 | 3.190 | 3.190 | 3.190 |
| Datum van publicatie | 13/05/19 | 15/05/20 | 14/05/21 | 13/05/22 | 15/05/23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 109.643 | 101.799 | 102.995 | 110.179 | 103.261 | 102.000 | 106.000 | 108.000 |
| EBITDA 1 | 13.507 | 11.538 | 14.745 | 17.081 | 11.179 | 8.300 | 10.100 | 11.000 |
| Bedrijfsresultaat (EBIT) 1 | 10.590 | 8.807 | 12.003 | 14.392 | 8.507 | 5.500 | 7.500 | 8.500 |
| Operationele Marge | 9,66% | 8,65% | 11,65% | 13,06% | 8,24% | 5,39% | 7,08% | 7,87% |
| Resultaat voor belastingen (EBT) 1 | 11.642 | 6.273 | 11.900 | 14.591 | 9.044 | 5.600 | 7.600 | 8.600 |
| Nettowinst (verlies) 1 | 8.435 | 4.598 | 8.587 | 10.569 | 6.649 | 4.400 | 5.900 | 6.650 |
| Nettomarge | 7,69% | 4,52% | 8,34% | 9,59% | 6,44% | 4,31% | 5,57% | 6,16% |
| WPA 2 | 212,9 | 117,6 | 222,3 | 277,4 | 178,9 | 123,9 | 166,1 | 187,2 |
| Free Cash Flow | 11.266 | - | - | - | 5.131 | - | 3.666 | 4.917 |
| FCF-marge | 10,28% | - | - | - | 4,97% | - | 3,46% | 4,55% |
| Kasstroomconversie (ebitda) | 83,41% | - | - | - | 45,9% | - | 36,3% | 44,7% |
| Kasstroomconversie (nettowinst) | 133,56% | - | - | - | 77,17% | - | 62,14% | 73,94% |
| Dividend per aandeel 2 | 85,00 | 80,00 | 90,00 | 90,00 | 80,00 | 80,00 | 80,00 | 80,00 |
| Datum van publicatie | 13/05/19 | 15/05/20 | 14/05/21 | 13/05/22 | 15/05/23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: Maart | 2020 S1 | 2021 S1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 51.512 | 51.623 | 26.647 | 54.009 | 30.805 | 25.365 | 27.692 | 25.508 | 53.200 | 28.194 | 21.867 | 24.747 | 24.729 | 49.476 | 28.742 | 23.782 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 6.200 | 7.229 | 2.948 | 6.131 | 6.914 | 1.347 | 4.265 | 1.014 | 5.279 | 5.077 | -1.849 | 2.515 | 1.437 | 3.952 | 1.839 | -291 |
| Operationele Marge | 12,04% | 14% | 11,06% | 11,35% | 22,44% | 5,31% | 15,4% | 3,98% | 9,92% | 18,01% | -8,46% | 10,16% | 5,81% | 7,99% | 6,4% | -1,22% |
| Resultaat voor belastingen (EBT) | 6.366 | 7.353 | - | 6.793 | 6.964 | - | 4.414 | - | 5.412 | 5.195 | - | 2.572 | - | 4.049 | 1.994 | - |
| Nettowinst (verlies) 1 | 4.592 | 5.411 | 2.263 | 4.916 | 5.264 | 389 | 3.155 | 768 | 3.923 | 4.158 | -1.432 | 1.688 | 1.150 | 2.838 | 1.606 | -44 |
| Nettomarge | 8,91% | 10,48% | 8,49% | 9,1% | 17,09% | 1,53% | 11,39% | 3,01% | 7,37% | 14,75% | -6,55% | 6,82% | 4,65% | 5,74% | 5,59% | -0,19% |
| WPA | 117,1 | 139,6 | - | 128,5 | 137,8 | - | 83,98 | - | 104,6 | 111,8 | - | 46,24 | - | 78,39 | 45,09 | - |
| Dividend per aandeel | 40,00 | 40,00 | - | 40,00 | - | - | - | - | 40,00 | - | - | - | - | 40,00 | - | - |
| Datum van publicatie | 5/11/19 | 2/11/20 | 5/11/21 | 5/11/21 | 4/02/22 | 13/05/22 | 1/08/22 | 4/11/22 | 4/11/22 | 6/02/23 | 15/05/23 | 4/08/23 | 2/11/23 | 2/11/23 | 5/02/24 | - |
1JPY in Miljoen
Geschatte gegevens
Balans
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - | - | - |
| Nettokaspositie 1 | 59.031 | 61.290 | 63.486 | 61.914 | 60.509 | 62.967 | 64.142 | 66.577 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Free Cash Flow | 11.266 | - | - | - | 5.131 | - | 3.666 | 4.917 |
| ROE (netto-inkomsten/eigen vermogen) | 6,9% | 3,7% | 6,9% | 8,3% | 5,2% | 3,4% | 4,5% | 5% |
| ROA (netto-inkomsten/totale activa) | 6,96% | 5,78% | 7,68% | 9,11% | 5,64% | 3,6% | 4,7% | 5,2% |
| Totale activa 1 | 121.212 | 79.490 | 111.813 | 116.028 | 117.819 | 122.222 | 125.532 | 127.885 |
| Nettoactief per aandeel 2 | 3.189 | 3.114 | 3.318 | 3.424 | 3.470 | 3.612 | 3.698 | 3.806 |
| Cashflow per aandeel | 286,0 | 187,0 | 293,0 | 348,0 | 251,0 | - | - | - |
| Capex 1 | 1.368 | 1.958 | 1.935 | 2.988 | 2.166 | 1.600 | 2.000 | 2.500 |
| Capex/omzet | 1,25% | 1,92% | 1,88% | 2,71% | 2,1% | 1,57% | 1,89% | 2,31% |
| Datum van publicatie | 13/05/19 | 15/05/20 | 14/05/21 | 13/05/22 | 15/05/23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
Verkoop
Koop
Gemiddeld advies
Houden
Aantal analisten
1
Laatste slotkoers
3.190
JPY
Gemiddelde koersdoel
3.200
JPY
Spread / Gemiddelde doel
+0,31%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -2,45% | 740 mln. | |
| +31,52% | 662 mld. | |
| +21,96% | 546 mld. | |
| -5,21% | 359 mld. | |
| +17,02% | 323 mld. | |
| +5,01% | 289 mld. | |
| +13,68% | 234 mld. | |
| +3,81% | 198 mld. | |
| -10,63% | 194 mld. | |
| +3,98% | 167 mld. |
- Beurs
- Aandelen
- Koers 4534
- Financiën Mochida Pharmaceutical Co., Ltd.
